Palm Springs bombing, LA wildfires, pushed labs to rethink monitoring, documentation, transport, and long-term storage governance
In the last decade, IVF cryostorage absorbed a handful of stress tests that accelerated developments in cryostorage. In March 2018, University Hospitals in Cleveland reported a storage tank failure that affected more than 4,000 eggs and embryos—an event that put equipment reliability, alarm escalation, and response protocols under national scrutiny. In the same month, Pacific Fertility Center in San Francisco disclosed the potential destruction of thousands of eggs and embryos after a tank failure, and the incident triggered years of litigation and broader questions about vendor risk and preventive maintenance discipline.
More recently, cryosafety planning has widened beyond mechanical failure. In May 2025, a vehicle bomb outside a Palm Springs fertility clinic led the FBI to describe the incident as terrorism. Multiple fertility clinics were threatened by the January 2025 Southern California wildfires, safely transporting their specimen tanks to a partner facility or to CryoFuture’s El Segundo facility. The 2025 events forced the field to confront physical security, facility hardening, and continuity planning as specimen-protection issues, not “operations” issues.
While such incidents are extremely rare, they still haunt the nightmares of embryologists who desperately want to protect their patients’ specimens. Taken together, these incidents created a clearer reality for lab directors: cryostorage risk is not dominated by one failure mode, and resilience depends on how well labs can detect, document, move, and defend specimens when conditions change quickly.
Labeling, witnessing, transfers, and documentation and other identity risks persist even when storage conditions remain stable. Needs for digital verification and auditability across laboratory work orders have gone beyond electronic witnessing as a point solution to needs for broader traceability solutions. ReproTech impressed industry observers in meeting this market demand early in its “significant growth investment” in IMT Matcher.
1M+ Embryos In Storage Meets “1 in 3 Babs” Still Monitoring By Hand
As cryopreserved inventories grow, the weak point is often not the tank—it’s the system around the tank. Clinics still rely on manual monitoring and periodic checks that leave no real-time visibility into tank conditions, increasing the chance a failure is detected late. Labs are shifting toward 24/7 oversight, validated transport, emergency tank replacement, and off-site options.
To prevent such incidents, CryoFuture and CEO Sean Pae, set out to address incomplete inventory controls, delayed detection, and relocation risk during emergencies. Its “layered response model” combines thermal imaging, weight sensors, redundant alarms, and a connected platform for real-time inventory management, with transport staffed by medically trained couriers and validated beyond manufacturer standards. CryoFuture provided support during wildfire evacuation threats, including specimen transport and on-demand tank replacement to maintain continuity without bypassing protocols.
HavenCryo also separated the burden of long-term storage from fertility centers’ day-to-day operations. The model places emphasis on hardened facilities, continuous monitoring, and geographic risk considerations, including site selection intended to reduce exposure to natural disasters. Centralization paired with planned transport reduces the likelihood that clinics must invent emergency storage or relocation solutions during periods of disruption.
30% Abandonment Signals A Governance Problem
Then there’s another risk class that has nothing to do with liquid nitrogen. It starts with consent drift, patient non-response, and inventories that become hard to reconcile. Abandoned cryostored specimens are a compound operational burden—staff time, documentation gaps, and legal exposure—made worse by manual outreach and inconsistent records. IT: The cost to fertility centers are overburdened teams, missed billing cycles, and unrecorded communication attempts that leave labs vulnerable when disposition decisions arise.
Fertility Billing Solution (FBS), led by CEO Shakil Kanji, automates notifications for renewals and payments, digital audit trails, patient self-service tools, and clearer consent pathways so clinics can document decisions and follow-ups consistently.FBS leans on the UK’s HFEA framework as an operational model—highlighting long storage horizons paired with required re-consent intervals and documented outreach expectations to reduce long-term liability tied to outdated directives. The intended outcome is fewer “specimens in limbo,” with clinics better able to show what they did, when they did it, and what the patient authorized.
ReproTech Invests In IMT Matcher
Specimen safety increasingly depends on traceability rather than tank performance alone. Identity verification, witnessing, and documentation failures can occur during freezing, labeling, movement, and handoff—even when temperature control is maintained. These process-level risks become more consequential as storage timelines stretch into years and as specimens pass through multiple custody environments.
In response to these pressures, ReproTech has aligned recent organizational and leadership changes around process-level safety rather than serve only part of the chain-of-custody. The company extended its approach to traceability through a strategic investment in IMT Matcher, an electronic witnessing and digital identity platform designed to reduce manual verification steps during specimen handling. “Their team, technology, mission, and values align perfectly with [ours],’ said Brad Senstra, Reprotech CEO. in a statement.
The investment strengthens chain-of-custody controls across extended storage timelines and multiple handoffs, positioning traceability as a core component of cryosafety rather than a secondary operational concern.
ReproTech has further introduced a refreshed brand identity signaling a broader emphasis on technology-enabled cryostorage, systems integration, and long-duration specimen stewardship. That shift coincided with the appointment of Mark Swift as Chief Innovation Officer, a role focused on advancing digital oversight, monitoring capabilities, and interoperability between clinics and storage environments to reduce fragmentation as specimens move between freezing, storage, and future use..
The way the cryosafety category is viewed by fertility providers shifted last year. Mechanical reliability remains necessary, but it is no longer sufficient. Continuous monitoring, validated movement, governance controls, and end-to-end traceability are now treated as interconnected requirements, shaped by the real-world failures and disruptions that have defined the last decade of IVF storage risk.
You Can Stop Being Left Out Now, Y’Know
Next Big Exposure Before PCRS. Why miss out when you get so much for so little? 🤪
If your organization belongs to this category but wasn’t included in this “State of” report, then your competitors are dominating the attention of your customers: REIs, fertility network executives, embryologists, and others.
These same competitors will get more coverage in a report or podcast episode, about your category
To start the year
Before PCRS
Before ESHRE
Before ASRM
Why let them get all the attention?
If you don’t want to miss out before PCRS, you have to join the IVF Heroes Universe as a sponsor now, before the next deadline.
You read it. Your employees read it. Your customers read it. Why miss out when you get so much for so little? 🤪